FOXO3 and breast carcinoma: HMGN2 is an anti-tumor effector molecule of CD8+T cells, FOXO3 is a core tumor suppressor in breast cancer; downregulation of PPP2R5E is a common event in acute myeloid leukemia [38,39,40].